Indian Drugmaker Eyes $250M Lannett Acquisition to Boost US Generics Footprint

Hyderabad-based pharmaceutical company targets strategic expansion into US market through potential landmark generic drug company purchase in 2025

ndtv-profit-business · 6/19/2026, 3:01:10 AM · Ask about this →